Back to Results
First PageMeta Content
Eye / Clinical pharmacology / Medical prescription / Patient safety / Vitreomacular adhesion / Macular hole / Macular degeneration / Macula of retina


SPECIAL AUTHORIZATION REQUEST FORM The Newfoundland and Labrador Prescription Drug Program (NLPDP) ® JETREA ocriplasmin 2.5 mg/ml Pharmaceutical Services Department of Health and Community Services
Add to Reading List

Document Date: 2015-07-10 08:30:48


Open Document

File Size: 174,24 KB

Share Result on Facebook